These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25238448)

  • 1. MITF positivity in atypical fibroxanthoma: a diagnostic pitfall.
    Tallon B; Beer TW
    Am J Dermatopathol; 2014 Nov; 36(11):888-91. PubMed ID: 25238448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
    Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
    Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.
    Choy B; Hyjek E; Montag AG; Pytel P; Haydon R; Luu HH; Zhen CJ; Long BC; Kadri S; Segal JP; Furtado LV; Cipriani NA
    Histopathology; 2017 Apr; 70(5):734-745. PubMed ID: 27926791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
    Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
    Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.
    Nybakken GE; Sargen M; Abraham R; Zhang PJ; Ming M; Xu X
    Am J Dermatopathol; 2013 Feb; 35(1):25-9. PubMed ID: 22668579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocytic differentiation is present in a significant proportion of nonpigmented diffuse neurofibromas: a potential diagnostic pitfall.
    Pižem J; Nicholson KM; Mraz J; Prieto VG
    Am J Surg Pathol; 2013 Aug; 37(8):1182-91. PubMed ID: 23715161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could the Study by Tallon and Beer Solve the Paradox of Primary Cutaneous PEComas?
    Fernandez-Flores A
    Am J Dermatopathol; 2016 Jan; 38(1):81-2. PubMed ID: 26730697
    [No Abstract]   [Full Text] [Related]  

  • 9. Sarcoma-like tumor of head and neck skin.
    Nonaka D; Bishop PW
    Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma simulating atypical fibroxanthoma.
    Sangüeza M; Zelger B
    Am J Dermatopathol; 2007 Dec; 29(6):551-4. PubMed ID: 18032950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma.
    Alaeddini M; Etemad-Moghadam S
    J Oral Pathol Med; 2015 Mar; 44(3):234-8. PubMed ID: 25048051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Atypical Fibroxanthoma and Intradermal Nevus Collision Tumor-Potential for Misdiagnosis.
    Steel A; Debbaneh M; Cassarino D
    Am J Dermatopathol; 2019 Aug; 41(8):e87-e89. PubMed ID: 31335430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
    Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
    Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoplastic nevus of chronically sun-damaged skin: an entity to be distinguished from desmoplastic melanoma.
    Sidiropoulos M; Sholl LM; Obregon R; Guitart J; Gerami P
    Am J Dermatopathol; 2014 Aug; 36(8):629-34. PubMed ID: 25051041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD163 is not a sensitive marker for identification of atypical fibroxanthoma.
    Beer TW
    J Cutan Pathol; 2012 Jan; 39(1):29-32. PubMed ID: 22211334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas.
    Helbig D; Mauch C; Buettner R; Quaas A
    J Cutan Pathol; 2018 Dec; 45(12):880-885. PubMed ID: 30155964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new AJCC guidelines in practice: utility of the MITF immunohistochemical stain in the evaluation of single-cell metastasis in melanoma sentinel lymph nodes.
    Hutchens KA; Heyna R; Mudaliar K; Wojcik E
    Am J Surg Pathol; 2013 Jun; 37(6):933-7. PubMed ID: 23629445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granular cell atypical fibroxanthoma: report of two cases.
    Ríos-Martín JJ; Delgado MD; Moreno-Ramírez D; García-Escudero A; González-Cámpora R
    Am J Dermatopathol; 2007 Feb; 29(1):84-7. PubMed ID: 17284969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical fibroxanthoma: new insights.
    Hussein MR
    Expert Rev Anticancer Ther; 2014 Sep; 14(9):1075-88. PubMed ID: 24958232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.